Systemic inflammation increases across distinct stages of advanced chronic liver disease and correlates with decompensation and mortality

Hepatology

Amelioration of systemic inflammation in advanced chronic liver disease upon beta-blocker therapy translates into improved clinical outcomes

Gut

Jachs M, Hartl L, Schaufler D, Desbalmes C, Simbrunner B, Eigenbauer E, Bauer DJM, Paternostro R, Schwabl P, Scheiner B, Bucsics T, Stättermayer AF, Pinter M, Trauner M, Mandorfer M, Reiberger T

doi: 10.1136/gutjnl-2020-322712

Hepatology

Model for end-stage liver disease-sodium underestimates 90-day mortality risk in patients with acute-on-chronic liver failuare

J Hepatol.

Hernaez R, Liu Y, Kramer JR, Rana A, El-Serag HB, Kanwal F

doi: 10.1016/j.jhep.2020.06.005.

Hepatology

Nonalcoholic Fatty Liver Disease Increases Risk of Incident Chronic Kidney Disease: a Systematic Review and Meta-Analysis

Metabolism.

Mantovani A, Zaza G, Byrne CD, Lonardo A, Zoppini G, Bonora E, Targher G

doi: 10.1016/j.metabol.

Hepatology

Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Implications for liver transplantation

Liver Transpl

Younossi ZM

doi: 10.1002/lt.25003.

Hepatology

Association between Advanced Fibrosis in Fatty Liver Disease and Overall Mortality based on Body Fat Distribution

J Gastroenterol Hepatol.

Chung GE, Heo NJ, Kim D, Kwak MS, Yim JY, Kim JS, Ahmed A

doi: 10.1111/jgh.14778.

Hepatology

Noninvasive Markers of Portal Hypertension Detect Decompensation in Overweight or Obese Patients With Compensated Advanced Chronic Liver Disease

Clin Gastroenterol Hepatol.

Mendoza Y, Cocciolillo S, Murgia G, Chen T, Margini C, Sebastiani G, Berzigotti A

doi: 10.1016/j.cgh.2020.04.018.

Hepatology

Improved prediction of mortality by combinations of inflammatory markers and standard clinical scores in patients with acute-on-chronic liver failure and acute decompensation

J Gastroenterol Hepatol.

Grønbaek H, Møller HJ, Saliba F, Zeuzem S, Albillos A, Ariza X, Graupera I, Solà E, Amoros A, Pavesi M, Bossen L, Jalan R, Gines P, Arroyo V, CANONIC investigators, EASL CLIF Consortium.

doi: 10.1111/jgh.15125.

Further Publications

Metabolic dysfunction-associated fatty liver disease is associated with increased all-cause mortality in the United States

J Hepatol

Kim D, Konyn P, Sandhu KK, Dennis BB, Cheung AC, Ahmed A

doi: 10.1016/j.jhep.2021.07.035

Gastrointestinal DiseasesHepatology

Assessment of prognostic performance of Albumin-Bilirubin, Child-Pugh, and Model for End-stage Liver Disease scores in patients with liver cirrhosis complicated with acute upper gastrointestinal bleeding

Eur J Gastroenterol Hepatol.

Xavier SA, Vilas-Boas R, Boal Carvalho P, Magalhães JT, Marinho CM, Cotter JB

doi: 10.1097/

Related content

Amelioration of systemic inflammation in advanced chronic liver disease upon beta-blocker therapy translates into improved clinical outcomes

Model for end-stage liver disease-sodium underestimates 90-day mortality risk in patients with acute-on-chronic liver failuare

Nonalcoholic Fatty Liver Disease Increases Risk of Incident Chronic Kidney Disease: a Systematic Review and Meta-Analysis

Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Implications for liver transplantation

Association between Advanced Fibrosis in Fatty Liver Disease and Overall Mortality based on Body Fat Distribution

Noninvasive Markers of Portal Hypertension Detect Decompensation in Overweight or Obese Patients With Compensated Advanced Chronic Liver Disease

Improved prediction of mortality by combinations of inflammatory markers and standard clinical scores in patients with acute-on-chronic liver failure and acute decompensation

Metabolic dysfunction-associated fatty liver disease is associated with increased all-cause mortality in the United States

Assessment of prognostic performance of Albumin-Bilirubin, Child-Pugh, and Model for End-stage Liver Disease scores in patients with liver cirrhosis complicated with acute upper gastrointestinal bleeding